Martin Van Trieste is a former chief quality officer at Amgen who was recently named one of Modern Healthcare’s 100 Most Influential People in Healthcare and the #2 leader on The Medicine Maker’s Power List of Industry Influencers. He brings over 35 years in the industry, with comprehensive experience in biopharmaceutical manufacturing, quality systems and related government regulations in the U.S. and around the world.
In 2019, Civica Rx’s first full year in operation, Martin led the Civica team as it grew its membership to include 45+ health systems, representing 1,200 hospitals across the U.S., and delivered its first essential medications to market to address drug shortages. Today, 18 Civica medications are in production, with many more to come, thanks to collaboration with health system pharmacy leaders who help prioritize the medications, and supplier partners. Civica will build its own manufacturing capability over time.
Prior to joining Civica and Amgen before that, Mr. Van Trieste was with Bayer Healthcare’s Biological Products Division as vice president of worldwide quality and Abbott Laboratories as the vice president of quality assurance for the Hospital Products Division.
Mr. Van Trieste is the founder of Rx-360, an international nonprofit organization that enhances patient safety by increasing security and quality in the biopharmaceutical supply chain. He has also served as the Chairman of the Parenteral Drug Association (PDA) Board of Directors.
Mr. Van Trieste earned a Pharmacy degree from Temple University School of Pharmacy.